Skip to main content

Table 2 Baseline characteristics of 479 patients with AF-associated FE-IS and TIA (risk factors and treatment)

From: Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt)

Variable (N*)

Death within 500 days

Survival of 500 days

p-value univariate

p-value multivariate

 

N (%)

    

Risk factors

     

CAD (465*/479)

144 (31%)

54 (37.5%)

90 (62.5%)

p=0.02

p=0.01

MI (475*/479)

84 (17.7%)

33 (39.3%)

51 (60.7%)

p=0.07

 

Heart failure (452*/479)

169 (37.4%)

62 (36.7%)

107 (63.3%)

p=0.01

p=0.94

PAD (461*/479)

48 (10.4%)

23 (47.9%)

25 (52.1%)

p=0.004

p=0.13

Hypertension (479*/479)

446 (93.1%)

136 (30.5%)

310 (69.5%)

p=0.70

 

Diabetes (478*/479)

157 (32.8%)

43 (27.4%)

114 (72.6%)

p=0.34

 

Hypercholesterolemia (470*/479)

285 (60.6%)

79 (27.7%)

206 (72.3%)

p=0.26

 

Smoking (400*/479)

   

p=0.24

 

Nonsmoker

206 (51.5%)

69 (33.5%)

137 (66.5%)

 

Smoker

42 (10.5%)

11 (26.2%)

31 (73.8%)

 

Former smoker

152 (38%)

39 (25.7%)

113 (74.3%)

 

GFR (461*/479)

   

p<0.0001

p=0.09

0-<30

16 (3.5%)

8 (50%)

8 (50%)

  

30-<60

160 (34.7%)

66 (41.3%)

94 (58.7%)

60

285 (61.8%)

65 (22.8%)

220 (77.2%)

Treatment (479*/479)

     

Intraveneous thrombolysis

   

p=0.62

 

Yes

47 (9.8%)

16 (34%)

31 (66%)

  

No

432 (90.2)

131 (30.3)

301 (69.7)

 

Antithrombotic treatment (479*/479)

     

OAK prior to stroke

116 (24.2%)

20 (17.2%)

96 (82.8%)

p=0.0003

p=0.91

INR <2

65 (58%)

15 (23.1%)

50 (76.9%)

  

INR ≥2

44 (39.3%)

4 (9.1%)

40 (90.9%)

  

INR unknown

7 (6%)

1 (14.3%)

6 (85.7%)

  

Antiplatelets prior to stroke (479*/479)

   

p<0.0001

 

No antiplatelet

298 (62.2%)

69 (23.2%)

229 (76.8%)

  

Antiplatelet

181(37.8%)

78 (43.1%)

103 (56.9%)

 

OAC management post stroke (479*/479)

   

p<0.0001

p<0.0001

No VKA

200 (41.8%)

127 (63.5%)

73 (37.5%)

OAC neither given, nor recommended

158 (79%)

109 (69%)

49 (31%)

OAC recommended, but not given

42 (21%)

18 (42.9%)

24 (57.1%)

VKA started in hospital

181 (37.8%)

16 (8.8%)

165 (91.2%)

VKA started post discharge

71 (14.8%)

2 (2.8%)

69 (97.2%)

Unknown

27 (5.6%)

2 (7.4%)

25 (93.6%)

Recurrent cerebral event (500days)

43/479 (9%)

21 (48.8%)

22 (51.2%)

p=0.009

p=0.27

IS

33 (76.7%)

19 (57.6%)

14 (42.4%)

TIA

6 (14%)

0

6

ICH

4 (9.3%)

2 (50%)

2 (50%)

  1. *Patients with complete information.
  2. Significant p-values in bold.